Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland

In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs in Context 2015-05, Vol.4, p.212280-9
Hauptverfasser: Kassianos, George, White, Sharon, Reynolds, Arlene J, Rajaram, Sankarasubramanian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue
container_start_page 212280
container_title Drugs in Context
container_volume 4
creator Kassianos, George
White, Sharon
Reynolds, Arlene J
Rajaram, Sankarasubramanian
description In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.
doi_str_mv 10.7573/dic.212280
format Article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4423484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0c8cc682d5ae40698280a05218f69227</doaj_id><sourcerecordid>1681258968</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</originalsourceid><addsrcrecordid>eNplkt9uFCEUxidGY2v1xgcwXBqTqcAAAzcmpmm1SRMT_1wTFs7s0MzACsy29jV8Ydnd2th4QeB8fOcHOfma5jXBpz3vu_fO21NKKJX4SXNMeoZb1in5dH_mLVGSHDUvcr7GmHEsxPPmiHLVU4X5cfP7K2w93KA4oDICgtsNJA_BQkZDivNeHHzKBdnRT26M0SEfhmmBcGfQ1ljrgyk-BrRJcZ3MPAO68WVEBk1-C8iUAmExBf5vg6qg87CeTHBot77ZWHbFy-bZYKYMr-73k-bHxfn3s8_t1ZdPl2cfr1rbcYXbAbjBRDje97SXeHAgFGYWC2bFajUYUIPBtMOOdaSXK4c7hxmxVhJZW5XrTprLA9dFc603yc8m_dLReL0XYlprk4q3E2hspbVCUscNMCyUrMM2mNOKEorSvrI-HFibZTWDsxBKMtMj6OOb4Ee9jlvNGO2YZBXw9h6Q4s8FctGzzxamOhCIS9ZESEK5VEJW67uD1aaYc4Lh4RmC9S4RuiZCHxJRzW_-_diD9W8Euj8KL7Sd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681258968</pqid></control><display><type>article</type><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</creator><creatorcontrib>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</creatorcontrib><description>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</description><identifier>ISSN: 1745-1981</identifier><identifier>ISSN: 1740-4398</identifier><identifier>EISSN: 1740-4398</identifier><identifier>DOI: 10.7573/dic.212280</identifier><identifier>PMID: 25972905</identifier><language>eng</language><publisher>England: Just Medical Media Limited</publisher><subject>children ; England ; Improving Practice ; influenza ; pilot project ; schools ; Scotland ; vaccination ; vaccine</subject><ispartof>Drugs in Context, 2015-05, Vol.4, p.212280-9</ispartof><rights>Copyright © 2015 Kassianos G, White S, Reynolds AJ, Rajaram S. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423484/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423484/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25972905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kassianos, George</creatorcontrib><creatorcontrib>White, Sharon</creatorcontrib><creatorcontrib>Reynolds, Arlene J</creatorcontrib><creatorcontrib>Rajaram, Sankarasubramanian</creatorcontrib><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><title>Drugs in Context</title><addtitle>Drugs Context</addtitle><description>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</description><subject>children</subject><subject>England</subject><subject>Improving Practice</subject><subject>influenza</subject><subject>pilot project</subject><subject>schools</subject><subject>Scotland</subject><subject>vaccination</subject><subject>vaccine</subject><issn>1745-1981</issn><issn>1740-4398</issn><issn>1740-4398</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNplkt9uFCEUxidGY2v1xgcwXBqTqcAAAzcmpmm1SRMT_1wTFs7s0MzACsy29jV8Ydnd2th4QeB8fOcHOfma5jXBpz3vu_fO21NKKJX4SXNMeoZb1in5dH_mLVGSHDUvcr7GmHEsxPPmiHLVU4X5cfP7K2w93KA4oDICgtsNJA_BQkZDivNeHHzKBdnRT26M0SEfhmmBcGfQ1ljrgyk-BrRJcZ3MPAO68WVEBk1-C8iUAmExBf5vg6qg87CeTHBot77ZWHbFy-bZYKYMr-73k-bHxfn3s8_t1ZdPl2cfr1rbcYXbAbjBRDje97SXeHAgFGYWC2bFajUYUIPBtMOOdaSXK4c7hxmxVhJZW5XrTprLA9dFc603yc8m_dLReL0XYlprk4q3E2hspbVCUscNMCyUrMM2mNOKEorSvrI-HFibZTWDsxBKMtMj6OOb4Ee9jlvNGO2YZBXw9h6Q4s8FctGzzxamOhCIS9ZESEK5VEJW67uD1aaYc4Lh4RmC9S4RuiZCHxJRzW_-_diD9W8Euj8KL7Sd</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Kassianos, George</creator><creator>White, Sharon</creator><creator>Reynolds, Arlene J</creator><creator>Rajaram, Sankarasubramanian</creator><general>Just Medical Media Limited</general><general>BioExcel Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150501</creationdate><title>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</title><author>Kassianos, George ; White, Sharon ; Reynolds, Arlene J ; Rajaram, Sankarasubramanian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3590-fe5a016d5772780fde6904c064c6bbfae9fa0230d43178bd03d041cc818fe59d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>children</topic><topic>England</topic><topic>Improving Practice</topic><topic>influenza</topic><topic>pilot project</topic><topic>schools</topic><topic>Scotland</topic><topic>vaccination</topic><topic>vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kassianos, George</creatorcontrib><creatorcontrib>White, Sharon</creatorcontrib><creatorcontrib>Reynolds, Arlene J</creatorcontrib><creatorcontrib>Rajaram, Sankarasubramanian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drugs in Context</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kassianos, George</au><au>White, Sharon</au><au>Reynolds, Arlene J</au><au>Rajaram, Sankarasubramanian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland</atitle><jtitle>Drugs in Context</jtitle><addtitle>Drugs Context</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>4</volume><spage>212280</spage><epage>9</epage><pages>212280-9</pages><issn>1745-1981</issn><issn>1740-4398</issn><eissn>1740-4398</eissn><abstract>In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.</abstract><cop>England</cop><pub>Just Medical Media Limited</pub><pmid>25972905</pmid><doi>10.7573/dic.212280</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1745-1981
ispartof Drugs in Context, 2015-05, Vol.4, p.212280-9
issn 1745-1981
1740-4398
1740-4398
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4423484
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects children
England
Improving Practice
influenza
pilot project
schools
Scotland
vaccination
vaccine
title Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20the%20experiences%20from%20the%20first%20childhood%20influenza%20vaccination%20programme%20with%20a%20live%20attenuated%20influenza%20vaccine%20in%20England%20and%20Scotland&rft.jtitle=Drugs%20in%20Context&rft.au=Kassianos,%20George&rft.date=2015-05-01&rft.volume=4&rft.spage=212280&rft.epage=9&rft.pages=212280-9&rft.issn=1745-1981&rft.eissn=1740-4398&rft_id=info:doi/10.7573/dic.212280&rft_dat=%3Cproquest_doaj_%3E1681258968%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1681258968&rft_id=info:pmid/25972905&rft_doaj_id=oai_doaj_org_article_0c8cc682d5ae40698280a05218f69227&rfr_iscdi=true